Aspire Biopharma Holdings, Inc. (ASBP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 236.8M |
| Enterprise Value | 237.18M |
| P/E Ratio | -1.1 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 10.46 |
| Price/Book Ratio | 0.78 |
| Enterprise/Revenue | -114.13 |
| Enterprise/EBITDA | -3.39 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -113.14 |
| Operating Margin | -72.6 |
| Return On Assets | -0.82 |
| Return On Equity | 19.93 |
| Revenue | 6,202 |
| Revenue/Share | 0.09 |
| Gross Profit | -116 |
| EBITDA | -11.33M |
| Net Income | -24.48M |
| Diluted EPS | -16.38 |
| Total Cash | 12.17M |
| Total Cash/Share | 11.72 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 7.99 |
| Book Value Per Share | 11.33 |
| 52-Week Change | -97.81 |
| 52-Week High | 562.8 |
| 52-Week Low | 0.11 |
| Moving Average 50 Days | 8.46 |
| Moving Average 200 Days | 4.68 |
| Average Volume | 33,283 |
| Shares Outstanding | 115,372 |
| % Held by Institutions | 1.7 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
| Last Split Date | May 11, 2026 |